NASDAQ · CRMD
CorMedix Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for CRMD: Nov 11, 2026
CorMedix Inc. Common Stock is estimated to report earnings on 11/11/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.05. The reported EPS for the same quarter last year was $0.57.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.05 | $-0.05 | $-0.05 | 1 |
| Dec 2026 | $-0.08 | $-0.08 | $-0.08 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · Fintel · The Motley Fool- RTTNews · Oct 19, 9:19 AM EDTCorMedix Gains FDA Priority Review For REZZAYO's Potential New Indication(RTTNews) – CorMedix Inc. (CRMD), a biopharmaceutical company focused on developing and commercializing therapies for life-threatening conditions, announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a supplemental New Drug Application (sNDA) for REZ
- RTTNews · Oct 19, 9:12 AM EDTCorMedix Wins Priority Review For REZZAYO SNDA In Fungal Disease Prevention(RTTNews) – Correction: Duplicate body text was removed to eliminate repetition and improve readability.
- Zacks · Oct 8, 10:40 AM EDTCRMD vs. PRTA: Which Stock Should Value Investors Buy Now?CRMD vs. PRTA: Which Stock Is the Better Value Option?
- Fintel · Sep 23, 5:15 PM EDTOppenheimer Initiates Coverage of CorMedix at OutperformFintel reports that on September 23, 2026, Oppenheimer initiated coverage of CorMedix (NASDAQGM:CRMD) (DB:19KA) with a Outperform recommendation.CorMedix Inc., headquartered in the United States, is a biopharmaceutical company mainly focused on developing and commercializing ther
- Zacks · Sep 7, 9:55 AM EDTWall Street Analysts Think CorMedix (CRMD) Could Surge 67.73%: Read This Before Placing a BetThe consensus price target hints at a 67.7% upside potential for CorMedix (CRMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Zacks · Aug 31, 12:00 PM EDTCorMedix (CRMD) Upgraded to Buy: Here's WhyCorMedix (CRMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- The Motley Fool · Aug 20, 10:14 AM EDTCorMedix (CRMD) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Aug 20, 9:55 AM EDTWall Street Analysts Believe CorMedix (CRMD) Could Rally 65.96%: Here's is How to TradeThe consensus price target hints at a 66% upside potential for CorMedix (CRMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Zacks · Aug 14, 9:43 AM EDTCRMD Stock Up as Q2 Earnings & Sales Beat on DefenCath, Melinta GainsCorMedix stock rises 15% after Q2 earnings and revenues beat estimates, driven by solid DefenCath utilization and contributions from the Melinta portfolio.
- MarketBeat · Aug 13, 11:06 AM EDTCorMedix Q2 Earnings Call HighlightsHigh Risk, High Reward: 3 Healthcare Stocks to Watch in 2026CorMedix (NASDAQ:CRMD) reported second-quarter 2026 consolidated revenue of $101.9 million and adjusted EBITDA of $58.7 million, while reaffirming its full-year revenue outlook and raising adjusted EBITDA guidance. The c
- Zacks · Aug 13, 8:45 AM EDTCorMedix (CRMD) Q2 Earnings and Revenues Top EstimatesCorMedix (CRMD) delivered earnings and revenue surprises of +11.54% and +7.64%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 12, 8:10 AM EDTHumacyte, Inc. (HUMA) Reports Q2 Loss, Misses Revenue EstimatesHumacyte, Inc. (HUMA) delivered earnings and revenue surprises of -60.00% and -70.79%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for CorMedix Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.